<DOC>
<DOCNO>EP-0624594</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Monomeric bile acid derivatives, a process for their production, and their use as medicines
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3158	C07J4300	C07J3100	A61P300	A61P910	C07J900	A61P900	A61K3158	C07J5100	A61K31575	A61K31575	C07J4100	C07J5100	C07J4300	C07J900	C07J3100	C07J4100	A61P306	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	C07J	C07J	A61P	A61P	C07J	A61P	A61K	C07J	A61K	A61K	C07J	C07J	C07J	C07J	C07J	C07J	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	C07J43	C07J31	A61P3	A61P9	C07J9	A61P9	A61K31	C07J51	A61K31	A61K31	C07J41	C07J51	C07J43	C07J9	C07J31	C07J41	A61P3	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Monomeric bile acid derivatives of the formula I  Z-X-GS      I, in which GS, X and Z have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST AG
</APPLICANT-NAME>
<APPLICANT-NAME>
HOECHST AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
ENHSEN ALFONS DR
</INVENTOR-NAME>
<INVENTOR-NAME>
GLOMBIK HEINER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
KRAMER WERNER DR DR
</INVENTOR-NAME>
<INVENTOR-NAME>
WESS GUENTHER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
ENHSEN, ALFONS, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
GLOMBIK, HEINER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
KRAMER, WERNER, DR. DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
WESS, GUENTHER, DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A monomeric bile acid derivative of the formula I

Z-X-GS

in which

GS
is a bile acid radical having an acid function in
the side chain or a salt thereof,
X
is a covalent bond or a bridge group of the
formula (CH
2
)
n
, where n = 1 to 10, in which the
alkylene chain can contain 1 to 3 oxygen atoms,

NH- or


and in which GS is bonded
via X as desired, and
Z
is

A bile acid derivative of the formula I as claimed
in claim 1, wherein GS is linked to X in the

3-position, linking taking place in the α- or β-position.
A medicament comprising a bile acid derivative as
claimed in claim 1.
A hypolipidemic agent comprising a bile acid derivative
as claimed in claim 1.
The use of a compound of the formula I as claimed in
either of claims 1 or 2 for the preparation of a

medicament for the treatment of hyperlipidemia.
</CLAIMS>
</TEXT>
</DOC>
